Bobba, S., Chauhan, K. S., Akter, S., Das, S., Mittal, E., Mathema, B., Philips, J. A., & Khader, S. A. (2024). A protective role for type I interferon signaling following infection with Mycobacterium tuberculosis carrying the rifampicin drug resistance-conferring RpoB mutation H445Y. PLOS Pathogens, 20(4), e1012137. https://doi.org/10.1371/journal.ppat.1012137

Paradkar, M. S., Devaleenal D, B., Mvalo, T., Arenivas, A., Thakur, K. T., Wolf, L., Nimkar, S., Inamdar, S., Giridharan, P., Selladurai, E., Kinikar, A., Valvi, C., Khwaja, S., Gadama, D., Balaji, S., Yadav Kattagoni, K., Venkatesan, M., Savic, R., Swaminathan, S., … Phillips, P. (2022). Randomized Clinical Trial of High-Dose Rifampicin With or Without Levofloxacin Versus Standard of Care for Pediatric Tuberculous Meningitis: The TBM-KIDS Trial. Clinical Infectious Diseases, 75(9), 1594–1601. https://doi.org/10.1093/cid/ciac208

Urusova, D. V., Merriman, J. A., Gupta, A., Chen, L., Mathema, B., Caparon, M. G., & Khader, S. A. (2022). Rifampin resistance mutations in the rpoB gene of Enterococcus faecalis impact host macrophage cytokine production. Cytokine, 151, 155788. https://doi.org/10.1016/j.cyto.2021.155788